Results 231 to 240 of about 3,384,133 (256)
Some of the next articles are maybe not open access.

Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy

Bioorganic Chemistry, 2019
DNMT and HDAC are closely related to each other and involved in various human diseases especially cancer. These two enzymes have been widely recognized as antitumor targets for drug discovery.
Zigao Yuan   +2 more
exaly   +2 more sources

An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives

Expert Opinion on Drug Discovery, 2021
Introduction HDACs catalyze the removal of acetyl groups from the ε-N-acetylated lysine residues of various protein substrates including both histone and nonhistone proteins.
Ma Su, Xing-Yu Gong, Feng Liu
semanticscholar   +1 more source

Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)

open access: yesPharmaceuticals
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreatic cancer characterized by therapy resistance and early metastasis, resulting in a low survival rate.
Marc Pflieger   +2 more
exaly   +3 more sources

HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway

Bioorganic Chemistry, 2021
Fangyuan Cao   +2 more
exaly  

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Nature Medicine
Feng Wang   +24 more
semanticscholar   +1 more source

Curcumin: A Natural Pan-HDAC Inhibitor in Cancer.

Current pharmaceutical design, 2018
Sara Saffar Soflaei   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy